UNASSIGNED: Background: This overview comments on the health-care relevance of peripheral @entity432 (PAOD) in @entity1 with @entity613 ( @entity613 ) and @entity4218 ( @entity4218 ). We evaluated different treatment modalities in terms of cost-effectiveness. Method: For the literature review, the Medline database (PubMed) was searched under the key words " @entity63 AND cost", " @entity63 AND economy", "peripheral @entity455 AND cost", "peripheral @entity455 AND economy". Results: In the years 2005 to 2009, the hospitalisations of @entity1 with PAOD rose disproportionately in Germany by 20%, to 483,961 hospital admissions. By comparison, hospital admissions altogether increased by only 8%. The average in- @entity1 costs were estimated to be approximately     5000 per PAOD- @entity1 - a rather conservative estimate. For the @entity1 with @entity613 the economic data position is clear, supervised exercise training is by far the most cost-effective treatment option, followed by percutaneous transluminal angioplasty (PTA) and finally the peripheral bypass. In accordance with the guidelines of the UK, the latter is therefore indicated only if @entity865 fails or is technically not possible. In @entity1 with @entity4218 , the situation is not obvious. Indeed, a short-term economic advantage can be calculated for the PTA, the long-term comparison of both methods, however, is impossible due to insufficient data. In addition, the risk factors for the @entity1 have to be included in the calculation. This was indeed demonstrated in the short-term, but could not be analysed in the long-term follow-up. Conclusion: The issue of greater cost-effectiveness of open or endovascular treatment in @entity1 with @entity4218 is uncertain, the studies and @entity1 populations are too heterogeneous. Further studies are urgently needed to structure the sequence of the various treatment options in guidelines and clinical pathways.

[Cost and Cost-Effectiveness in the Treatment of Peripheral XXXX - What is Proven?]

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity455 :: ('MESH:D014652', 'Disease') :: ['arterial disease'] @entity63 :: ('MESH:D007511', 'Disease') :: ['critical limb ischemia'] @entity4218 :: ('MESH:D017880', 'Disease') :: ['CLI', 'critical limb ischaemia'] @entity613 :: ('MESH:D007383', 'Disease') :: ['intermittent claudication', 'IC'] @entity865 :: ('CHEBI:61432', 'Chemical') :: ['PTA'] @entity432 :: ('MESH:D001157', 'Disease') :: ['arterial occlusive disease']
@entity432 :: (MESH:D001157,Disease) :: ['Arterial Occlusion Disease']
